METASTATIC PANCREATIC ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test vitamin d combo to boost chemo against tough pancreatic cancer
Disease control CompletedThis study tested whether adding two drugs, paricalcitol (a form of vitamin D) and hydroxychloroquine, to standard chemotherapy could better control advanced pancreatic cancer that has spread. The goal was to see if this four-drug combination could shrink tumors more effectively …
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 20:26 UTC
-
Three-drug attack on deadly pancreatic cancer tested in patients
Disease control CompletedThis study tested whether combining three existing drugs could better control advanced pancreatic cancer that had spread. Sixty-three patients received gemcitabine by IV, trastuzumab by IV, and erlotinib as a daily pill. Researchers measured how well the combination stopped or sl…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for pancreatic cancer patients after first treatment fails
Disease control CompletedThis completed Phase 3 trial tested whether adding paclitaxel to gemcitabine helps people with advanced pancreatic cancer live longer compared to gemcitabine alone. The study involved 211 patients whose cancer had spread and didn't respond to their initial chemotherapy. Researche…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for deadly pancreatic cancer: immunotherapy trial seeks better treatments
Disease control CompletedThis early-stage trial tested whether adding immunotherapy drugs to standard chemotherapy could help people with newly diagnosed metastatic pancreatic cancer. The study enrolled 45 participants who hadn't received prior treatment for their advanced cancer. Researchers tested diff…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Cancer Insight, LLC • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New hope to halt devastating weight loss in pancreatic cancer patients
Symptom relief CompletedThis study tested if adding a drug called telotristat ethyl to standard chemotherapy could help patients with advanced pancreatic cancer stop losing weight. The goal was to see if stabilizing weight could help patients better tolerate their cancer treatment and potentially improv…
Matched conditions: METASTATIC PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Mar 31, 2026 12:10 UTC